NCT06578416 The Development of Stuttering in Young Children
| NCT ID | NCT06578416 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Michigan State University |
| Condition | Stuttering |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2023-06-01 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2023-06-01 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this longitudinal research is to learn why some children "grow out" of stuttering, while others persist. Children who do and do not stutter aged 3-6 years are eligible to participate in our study. During the study, children's speech and language abilities will be assessed with standardized assessments, and they complete several child-friendly experiments. During these experiments, brain activity will be recorded using specialized caps while children describe pictures, children will speak in two virtual-reality scenarios, and produce speech while keeping to a beat.
Eligibility Criteria
Inclusion Criteria for controls: * English as first/primary language * No history of neurological disease * Normal or corrected visual acuity * No medications expected to affect performance * No intellectual impairment, autism spectrum disorder, ADHD * Age-appropriate scores on speech and language assessment battery * Pass hearing screening at 20 dB at 500, 1000, 2000, and 4000, bilaterally Inclusion Criteria for children who stutter: * English as first/primary language * No history of neurological disease * Normal or corrected visual acuity * No medications expected to affect performance * No intellectual impairment or ASD Scores on speech and language assessments indicating stuttering, phonological (speech sound), or language disorders * Pass hearing screening at 20 dB at 500, 1000, 2000, and 4000, bilaterally
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06578416 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, up to 6 Years, studying Stuttering. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06578416 currently recruiting?
Yes, NCT06578416 is actively recruiting participants. Contact the research team at msustutteringlab@gmail.com for enrollment information.
Where is the NCT06578416 trial being conducted?
This trial is being conducted at East Lansing, United States.
Who is sponsoring the NCT06578416 clinical trial?
NCT06578416 is sponsored by Michigan State University. The trial plans to enroll 120 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.